Giridharan Ramsingh, M.D.

Peer-reviewed Publications

• Ramsingh G, Westervelt P, Cashen AF, Uy GL, Stockerl-Goldstein K, Abboud CN, Bernabe N, Monahan R, Dipersio JF, Vij R
  A phase 1 study of concomitant high dose lenalidomide and 5-azacitidine induction in the treatment of AML.
  Leukemia 2012 Jul 25; [Epub ahead of print]
• Ramsingh G, Koboldt DC, Trissal M, Chiappinelli KB, Wylie T, Koul S, Chang LW, Nagarajan R, Fehniger TA, Goodfellow P, Magrini V, Wilson RK, Ding L, Ley TJ, Mardis ER, Link DC
  Complete characterization of the microRNAome in a patient with acute myeloid leukemia.
  Blood 2010 Dec 9;116(24):5316-5326
• Fehniger TA, Wylie T, Germino E, Leong JW, Magrini VJ, Koul S, Keppel CR, Schneider SE, Koboldt DC, Sullivan RP, Heinz ME, Crosby SD, Nagarajan R, Ramsingh G, Link DC, Ley TJ, Mardis ER
  Next-generation sequencing identifies the natural killer cell microRNA transcriptome.
  Genome Res 2010 Nov;20(11):1590-604
• Ramsingh G, Mehan P, Luo J, Vij R, Morgensztern D
  Primary plasma cell leukemia: a Surveillance, Epidemiology, and End Results database analysis between 1973 and 2004.
  Cancer 2009 Dec 15;115(24):5734-9
• Ramsingh G, Mehan P, Morgensztern D, Luo J, Vij R
  Prognostic factors influencing survival in solitary plasmacytoma.
  Br J Haematol 2009 May;145(4):540-2
• Advani AS, Jin T, Ramsingh G, Tiu R, Saber W, Theil K, Sobecks R, Sekeres M, Copelan E, Sungren S, Tripp B, Kalaycio M
  Time to post-remission therapy is an independent prognostic factor in adults with acute lymphoblastic leukemia.
  Leuk Lymphoma 2008 Aug;49(8):1560-6
• Thakkar SG, Fu AZ, Sweetenham JW, Mciver ZA, Mohan SR, Ramsingh G, Advani AS, Sobecks R, Rybicki L, Kalaycio M, Sekeres MA
  Survival and predictors of outcome in patients with acute leukemia admitted to the intensive care unit.
  Cancer 2008 May 15;112(10):2233-40
• Aboudola S, Murugesan G, Szpurka H, Ramsingh G, Zhao X, Prescott N, Tubbs RR, Maciejewski JP, Hsi ED
  Bone marrow phospho-STAT5 expression in non-CML chronic myeloproliferative disorders correlates with JAK2 V617F mutation and provides evidence of in vivo JAK2 activation.
  Am J Surg Pathol 2007 Feb;31(2):233-9